Official recall record
BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175
- Issuing authority
- US FDA — Medical Devices
- Recall initiated by firm
- 2024-01-08
- Country of alert
- United States
- Alert level
- Class II
- Alert type
- recall
- Barcode (EAN/GTIN)
- 00382902321743
- Brand on record
- Becton Dickinson & Co.
What the authority reported
There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
What to do
Follow the instructions in the official notice — recall remedies (refund, repair, replacement, or disposal) are defined by the issuing authority and the responsible business, and they differ per recall. Do not rely on summaries, including this one.
Verify at the source:
US FDA — Medical Devices — official record →
Record last checked against the registry on 2026-05-31.
Record last checked against the registry on 2026-05-31.
Other recalls from this brand
- 2025-09-23 · US FDA — Medical Devices
BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 System, Catalog Numbers: 445570, 4 - 2025-09-23 · US FDA — Medical Devices
BD EpiCenter Microbiology Data Management System, labeled as the following: 1. Computer System Epicenter F/ - 2024-10-31 · US FDA — Medical Devices
BD MAX System, BD MAX Instrument Version or Model: 441916 Catalog Number: 441916
All 43 official recall notices naming Becton Dickinson & Co. on this site →
ProductGuru Recalls republishes official safety information with attribution. We are not
the issuing authority and this page is not advice. If this product is a medical device or
medication, speak to a doctor or pharmacist. Found an error?
Report it — corrections are published.